Home
News
May 2, 2012
Not intended for U.S. and UK media:
Bayer’s Xarelto® (Rivaroxaban) Submitted to U.S. FDA for the Treatment of Venous Thromboembolism (VTE) and Long-Term Prevention of Recurrent VTE
» more
April 27, 2012
Management Board Chairman Dr. Marijn Dekkers at the Annual Stockholders’ Meeting of Bayer AG:
Bayer has great potential for the future too
» more
April 26, 2012
1st quarter of 2012:
Encouraging start to the year for Bayer
» more
News Overview
April 26, 2012
Stockholders' Newsletter First Quarter 2012
» Online version
» Download PDF (2918 KB)
February 28, 2012
Annual Report 2011
» Online version
» Download PDF (8800 KB)
October 27, 2011
Stockholders' Newsletter Third Quarter 2011
» Online version
» Download PDF (2023 KB)
July 30, 2011
Stockholders' Newsletter Second Quarter 2011
» Online version
» Download PDF (2135 KB)
Previous Annual Reports
Previous Stockholders' Newsletters
Seite drucken
Search
Search
Stockholders' Newsletter First Quarter 2012
Annual Report 2011
Stockholders' Newsletter Third Quarter 2011
Stockholders' Newsletter Second Quarter 2011
All Financial Reports
All Bayer Websites
Advanced Search
Services
Order print version
Subscribe to Business and Finance Newsletter
Subscribe to an e-mail notification service for the new issue of financial publications
Receive the latest Investor Relations News headlines as an SMS
Subscribe to RSS feeds
Calendar
Calendar Overview
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Press
Jobs and Career
Foundations
Sports
Culture
Social Media
» Bayer Group
Deutsch
Search
RSS
Contact
zoom +
normal view 100%
zoom -